Al-Amri et al. reported that pretreatment with EGCG decreased TNF-α and NO, and markedly increased the number and density of TH-immunoreactive neurons in the midbrain of PD model rats (Al-Amri et al., 2013). The gene discussed is TNF; the disease is Parkinson disease.